WO2000051679A1 - Pseudo-fusion management during automatic capture verification - Google Patents
Pseudo-fusion management during automatic capture verification Download PDFInfo
- Publication number
- WO2000051679A1 WO2000051679A1 PCT/US1999/019983 US9919983W WO0051679A1 WO 2000051679 A1 WO2000051679 A1 WO 2000051679A1 US 9919983 W US9919983 W US 9919983W WO 0051679 A1 WO0051679 A1 WO 0051679A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- stimulation
- management device
- rhythm management
- intrinsic
- accordance
- Prior art date
Links
- 238000012795 verification Methods 0.000 title claims description 10
- 230000000638 stimulation Effects 0.000 claims abstract description 91
- 238000000034 method Methods 0.000 claims abstract description 46
- 230000033764 rhythmic process Effects 0.000 claims abstract description 46
- 230000000747 cardiac effect Effects 0.000 claims abstract description 42
- 238000001514 detection method Methods 0.000 claims abstract description 30
- 230000004936 stimulating effect Effects 0.000 claims abstract description 5
- 230000004044 response Effects 0.000 claims description 22
- 230000000763 evoking effect Effects 0.000 claims description 9
- 230000001419 dependent effect Effects 0.000 claims description 2
- 238000007726 management method Methods 0.000 abstract description 32
- 210000005003 heart tissue Anatomy 0.000 abstract description 3
- 208000033988 Device pacing issue Diseases 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 230000004927 fusion Effects 0.000 description 14
- 206010047289 Ventricular extrasystoles Diseases 0.000 description 9
- 238000000718 qrs complex Methods 0.000 description 7
- 230000028161 membrane depolarization Effects 0.000 description 6
- 230000002107 myocardial effect Effects 0.000 description 4
- 238000010276 construction Methods 0.000 description 3
- 230000003111 delayed effect Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000002837 heart atrium Anatomy 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 210000004165 myocardium Anatomy 0.000 description 3
- 230000035699 permeability Effects 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 208000002330 Congenital Heart Defects Diseases 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 208000006218 bradycardia Diseases 0.000 description 2
- 230000036471 bradycardia Effects 0.000 description 2
- 230000005831 heart abnormality Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 206010003671 Atrioventricular Block Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 208000034423 Delivery Diseases 0.000 description 1
- 208000010271 Heart Block Diseases 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 102100026827 Protein associated with UVRAG as autophagy enhancer Human genes 0.000 description 1
- 101710102978 Protein associated with UVRAG as autophagy enhancer Proteins 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 230000001746 atrial effect Effects 0.000 description 1
- 230000001364 causal effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000002999 depolarising effect Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 230000002861 ventricular Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/362—Heart stimulators
- A61N1/37—Monitoring; Protecting
- A61N1/371—Capture, i.e. successful stimulation
- A61N1/3712—Auto-capture, i.e. automatic adjustment of the stimulation threshold
Definitions
- the present invention relates generally to a method of delivering a stimulation pulse to a patient's heart utilizing a cardiac rhythm management device, and more particularly relates to a method of reducing the affects of intrinsic detection latency during an automatic capture and/or sensing threshold determination.
- the method of the present invention is initiated immediately prior to delivering a stimulation pulse to the heart tissue, wherein delivery of the stimulation is terminated or delayed if the amplitude of a portion of a sensed electrogram signal exceeds a predetermined threshold. Further, the method of the present invention minimizes the delivery of stimulation pulses proximate in time with an intrinsic event due to intrinsic detection latency (pseudo-fusion).
- Cardiac rhythm management devices have enjoyed widespread use and popularity throughout time as a means for supplanting some or all of the natural pacing functions of an abnormal heart.
- various heart abnormalities remedied by cardiac rhythm management devices include total or partial heart block, bradycardia, tachycardia, myocardial infarctions, congestive heart failure, congenital heart disorders, and various other arrhythmias and rhythm disturbances within the heart.
- the fundamental components of a rhythm management device include an electronic pulse generator for generating stimulation pulses to the heart and an electrode arrangement for both delivering the stimulation pulses and sensing intrinsic and/or evoked events of the heart.
- rhythm management devices may be designed to stimulate the ventricle, atrium or both the ventricles and atriums depending upon the heart abnormality. Regardless of the type of rhythm management device employed to restore the heart's natural rhythm, all operate to stimulate heart tissue cells adjacent to an electrode which is employed in the heart and electrically coupled to the rhythm management device.
- the delivery of the stimulation pulse is often dependent upon a preprogrammed timing sequence. Without limitation, the timing sequence may, for example, depend upon sensing or failure to sense an intrinsic event during a period that is measured from a previous sensed intrinsic event or prior stimulation. If certain predetermined requirements are not met during the timing sequence, then the rhythm management device may be preprogrammed to generate and deliver a stimulation pulse to the heart. When the stimulation evokes a response in the heart, this response is typically referred to as "capture" and is a function of the positive and negative charges found in each myocardial cell within the heart.
- the success of the cardiac rhythm management device in depolarizing or "capturing" the heart hinges on whether the energy of the stimulation pulse as delivered to the myocardium exceeds a threshold value.
- This threshold value referred to as the capture threshold, represents the amount of electrical energy required to alter the permeability of the myocardial cells to thereby initiate cell depolarization. If the energy of the stimulation pulse does not exceed the capture threshold, then the permeability of the myocardial cells will not be altered and thus no depolarization will result. If, on the other hand, the energy of the stimulation pulse exceeds the capture threshold, then the permeability of the myocardial cells will be altered such that depolarization will result. Changes in the capture threshold may be detected by monitoring the efficacy of stimulating pulses at various energy levels.
- the ability to detect capture is extremely desirable in that delivering stimulation pulses having energy far in excess of the patient's capture threshold is wasteful of the rhythm management devices limited power supply.
- capture verification a process known as “capture verification” must be performed wherein the rhythm management device monitors to determine whether an evoked depolarization or intrinsic event occurs in the heart following the delivery of each stimulus pulse.
- a stimulation pulse may be delivered coincidental to a depolarization by an intrinsic beat (hereinafter referred to as "fusion" or "a fusion beat").
- fusion beats manifest themselves by a pacing spike followed by an intrinsic QRS complex.
- a stimulation pulse may be delivered after intrinsic activation has already begun (hereinafter referred to as pseudo-fusion). From a surface ECG, it is seen that the stimulation pulse falls inside the intrinsic QRS complex.
- the stimulation pulses may or may not capture the myocardium.
- fusion and/or pseudo-fusion beats may be of little consequence except some energy loss due to unnecessary pacing output. However, during autocapture or autothresholding, the impact of fusion or pseudo-fusion can be rather different.
- fusion beats may be detected as capture for amplitude-based detection methods.
- the threshold may be identified at a lower amount than the actual threshold.
- Pseudo-fusion may be detected either as capture or non-capture depending upon timing of the occurrence of pseudo-fusion. If a stimulation pulse is delivered at an earlier portion of the QRS complex, then the stimulation pulse is more likely to be detected as capture and the consequence is the same as a fusion beat. If pseudo-fusion is detected as non-capture, a backup pulse may be issued between the QRS complex and a T wave which is undesirable.
- pseudo-fusion beats may cause false detection of either capture or non-capture.
- an error in threshold measurement may arise.
- occurrence of pseudo-fusion is caused by the inherent latency of sensing an intrinsic event. This latency often results from a sensing threshold level that is normally higher than front portions of the QRS complex of the endocardial signals, which prevents a detection by the rhythm management device of the front portions of the QRS complex.
- Other factors that may contribute to latency in intrinsic detection include sensing channel phase delay.
- the purpose of the present invention is to provide a method of delivering a stimulation pulse to a patient's heart utilizing a cardiac rhythm management device, wherein the method reduces the affects of intrinsic detection latency during an automatic capture and/or sensing threshold determination.
- the method of the present invention may be implemented in cardiac pacers, defibrillators and other rhythm management devices.
- the method of delivering stimulation pulses to a patient's heart will be described with reference to pacing a patient's heart and the timing sequences utilized in pacing the heart.
- the method of the present invention may equally apply to other rhythm management devices including defibrillators having known conventional timing sequences.
- the method of the present invention utilizes a cardiac rhythm management device of suitable known construction, wherein the rhythm management device includes sensing means for sensing cardiac electrogram signals, a programmable controller coupled to receive the sensed electrogram signals, and stimulation means controlled by the controller for applying cardiac stimulation pulses to a patient's heart in response to control signals from the controller.
- the stimulation means and sensing means may comprise circuitry electrically coupled a part of the controller.
- the programmable controller may be programmed to function utilizing the following sequence for initiating and delivering a stimulation pulse on a beat to beat basis or during an autocapture or autothreshold determination.
- the sensing circuit or sensing means is set to include a first sensing threshold level.
- the controller utilizes a stimulation timing sequence that determines when the next stimulation pulse should be delivered. Those skilled in the art will appreciate that the determination of when the stimulation pulse is delivered may depend on several variables and includes a predetermined timing sequence that depends on the last sensed intrinsic event or prior delivered stimulation pulse.
- the controller analyzes the electrogram signals to determine if an amplitude of a portion of the electrogram signals exceeds the first sensing threshold level. Without limitation, other means of known suitable construction may be utilized to determine whether an intrinsic event has been initiated. If the amplitude exceeds the first sensing threshold level, then delivery of the stimulation pulse is delayed by a second preset time.
- the controller determines whether an intrinsic event occurs during the second preset time. If no intrinsic event occurs during the second preset time, then a backup stimulation pulse having a predetermined output is delivered to the heart, wherein the output of the backup stimulation pulse is sufficient such that capture of the stimulus may be assumed.
- the stimulation sequence may be adapted by the controller during beat to beat delivery of a stimulation pulse or when delivering a stimulation pulse during autocapture or autothreshold determination. During the stimulation sequence, if the amplitude of a portion of the electrogram signal does not exceed the first sensing threshold level within the first preset time, then the likelihood of fusion or pseudo-fusion is remote and the stimulation pulse is delivered in accordance with the prescribed timing sequence. If an intrinsic event occurs during the second preset time, a preset R-R interval of the timing sequence is extended.
- the method of the present invention enhances early intrinsic detection threshold to monitor lower level intracardiac activities.
- the event threshold or first sensing threshold may be set at 0.5 millivolts.
- One suitable determination of the sensing threshold is described in greater detail in co-pending application serial number 09/094,773 filed June 15, 1998 and assigned to the same assignee as the present application, the entire disclosure of which is incorporated herein by reference for any purpose.
- autothreshold refers to a f lly automated method of measuring the stimulation threshold in either the atrium or ventricle.
- Autothreshold determination is distinguishable from a semi-automatic threshold test during which the operator identifies whether or not a pacing stimulus is followed by a causal depolarization.
- autothreshold determination is distinguishable from automatic capture detection or automatic output optimization. Unlike these features, autothreshold determination does not change the output values of the stimulation pulse.
- the controller preferably autonomously performs amplitude threshold testing periodically in order to collect a chronological trend that can be interrogated and analyzed during follow-up procedures.
- the threshold results can be displayed in histogram format and the programmer can suggest a safety margin based on the distribution characteristics of the threshold test results.
- Still another object of the present invention is to provide a cardiac rhythm management device that reduces the affects of fusion and pseudo-fusion during autocapture and autothreshold determination.
- Figure 1 is a partial sectional fragmentary view of a patient's heart having atrial and ventricular leads positioned therein, and a strip chart tracing of an electrogram waveform identifying capture, non-capture and fusion together with the corresponding strip chart tracing of a surface ECG shown for comparison and reference;
- Figure 2 is a graph showing pseudo-fusion which is detected as non-capture and resulting in pacing during an intrinsic and a backup pace proximate in time with a t-wave or vulnerable period following an intrinsic event
- Figure 3 are graphs showing the timing of a stimulation pulse delivered during various stages of a captured or intrinsic event
- Figure 4 shows a strip chart tracing showing "pseudo-fusions" detected as capture and non-capture and the resulting stimulation sequences, together with a strip chart tracing of a surface ECG for reference;
- Figure 5 shows a strip chart tracing showing the stimulation sequence including two
- Figure 6 is a flow chart showing a beat by beat capture verification sequence that includes delivery of a stimulation pulse with a pre-look
- Figure 7 is a flow chart showing an autothreshold sequence that includes delivering a stimulation pulse with a pre-look.
- Figure 8 is a flow chart showing the delivery of a stimulation pulse with a pre-look.
- the rhythm management device may include a programmable controller having pacing and sensing circuitry and may also include read-only memory (ROM) and random access memory (RAM) communicatively coupled to the programmable controller.
- ROM read-only memory
- RAM random access memory
- the cardiac rhythm management device may likewise include a transceiver cooperatively operable with an input/output module to thereby transmit and receive information to and from an external programmer. Electrodes of known suitable construction are electrically coupled to the cardiac rhythm management device and the controller contained therein, such that a stimulation pulse may be delivered to a desired location of the heart through the electrodes.
- FIG. 1 a strip chart and graph are shown in Figures 1 and 2, wherein the affects of fusion and pseudo-fusion in a pacing scheme are shown.
- the three waveforms 11, 13, and 15 correspond to a signal transmitted from a surface electrocardiogram, an associated pacing marker, and a processed signal transmitted from an intracardiogram respectively.
- the timing sequence in Figure 1 shows an intrinsic event 10 and then a period of time transpiring without a detection of another intrinsic event. After a predetermined amount of time transpires without detecting an intrinsic event, a pacing stimulus 12 is delivered which evokes a response at 14.
- the timing sequence shown in Figure 1 continues to deliver pacing stimulus if an intrinsic event is not sensed within a predetermined time.
- the pacing stimulus 16 is delivered in accordance with the predetermined timing sequence, but results in a fusion beat because the pacing stimulus 16 is delivered at the beginning of an intrinsic event 18.
- fusion and capture may be distinguished from a surface electrocardiogram waveform, fusion and capture beats are not distinguishable from the intracardiogram waveform 15.
- a pacing stimulus 20 may be delivered during a QRS complex, thus requiring a backup pace 22 proximate the T-wave or vulnerable period 24. Delivery of a backup pace 22 proximate the vulnerable period may lead to an undesirable arrhythmia and may be avoided by reducing fusion and pseudo-fusion during autocapture and autothreshold determination.
- Figure 3 further illustrates four possible timing sequences when delivery of a pacing stimulus 26.
- the timing sequence identified as "Capture” shows delivery of a pacing stimulus that evokes a response.
- the other three timing sequences show delivery of a pacing stimulus proximate with an intrinsic event 28.
- FIG. 4 strip charts of a portion of an electrogram single are shown which illustrate the affects of fusion and pseudo-fusion on a pacing interval and mode (see Figure 4) and the implementation of the present invention to avoid fusion and pseudo-fusion (see Figure 5).
- the waveforms 30-34 and associated pacing marker 36 shown in Figure 4 illustrate the affects of a fusion or pseudo-fusion beat on the ability to accurately determine capture or autothreshold.
- the waveform 30 results from a signal transmitted from a surface electrocardiogram.
- the waveform 32 results from a signal transmitted from an intracardiogram and processed through a wideband channel of approximately 6-200Hz.
- the waveform 34 results from a signal transmitted from an intracardiogram and processed through a narrower band channel of approximately 10-100Hz.
- the intrinsic event identified at 38 is not identified by the pacer and therefore a pace 40 is initiated followed by a backup pace.
- the pacing stimulus does not evoke a response and the controller process then concludes that the pacing stimulus at 40 did not evoke a response (non-capture).
- the pacing stimulus at 42 immediately precedes an intrinsic event 44, which results in a fusion beat and also affects an accurate determination of capture.
- the waveforms 56-60 and associated pacing marker 62 shown in Figure 5 illustrates delivery of a pacing stimulus with a pre-look.
- the waveform 56 results from a signal transmitted from a surface electrocardiogram.
- the waveform 58 results from a signal transmitted from an intracardiogram and processed through a wideband channel of approximately 6-200Hz.
- the waveform 60 results from a signal transmitted from an intracardiogram and processed through a narrower band channel of approximately 10- 100Hz.
- a controller of the rhythm management device initiates a beat by beat capture verification at block 80.
- the controller updates the evoked response detection threshold (see block 82) and a determination is made whether an intrinsic event is sensed or whether the amplitude of a selected portion of the electrogram signal exceeds the intrinsic detection threshold (see decision block 84). If an intrinsic event is sensed, the controller determines if an intrinsic event is sensed in the next cycle (see loop 86).
- a pacing stimulation is delivered with prelook (see block 90). Delivery of a stimulation pulse with prelook will be further discussed below in conjunction with a discussion of Figure 8.
- the controller determines whether the output or pacing stimulus results in an evoked response or capture (see decision block 92). If the stimulation pulse results in capture, the evoked response detection threshold is updated and the previous steps are repeated (see loop 94) and beat by beat pacing continues.
- the controller initiates a backup pace within a predetermined time (see block 96) and the RR interval is extended by a predetermined amount (see block 98).
- the backup pace is preferably initiated within 100ms and the RR interval is extended by 10% or by 80 ms.
- the controller determines whether an intrinsic event occurs within a predetermined time (see decision block 100). If an intrinsic event is sensed at decision block 100, then the extended RR interval is kept and the controller determines if an intrinsic event is sensed in the next cycle (see loop 102 and block 104).
- a stimulation pulse with prelook is delivered (see block 106) and capture of this pulse is determined (see decision block 108). If the stimulation with prelook results in capture then beat by beat pacing continues (see loop 110). If, however, the stimulation with prelook does not evoke a response, then a backup pace is initiated within a predetermined time (see block 112) and the controller switches to an autothreshold determination.
- FIG. 7 is a flowchart representation of an autothreshold determination of the present invention.
- the evoked response detection threshold is set or updated (see block 116).
- a stimulation pulse with prelook is delivered having a predetermined output (see block 118) and the controller determines whether the stimulation pulse evokes an intrinsic response (see decision block 120). If the stimulation pulse results in capture, the pacing output is updated (see block 122) and the pacing output is compared with a preset minimum threshold output (see decision block 124). If the pacing output is equal to the preset minimum threshold output, then autothreshold determination is terminated (see block 126).
- the pacing rate is updated for every third beat (see block 128) by extending the RR interval as described previously and autothreshold determination continues (see loop 130). If the stimulation pulse is not captured at decision block 120, then a backup pace having a predetermined output is delivered (see block 132) and the controller attempts to confirm non-capture (see decision block 134). If the controller does not confirm non-capture, then the pacing output remains the same, the RR interval is extended (see block 136) and autothreshold determination continues (see loop 138). If, however, the output results in non-capture, the threshold is set equal to the previous pace output level (see block 140) and autothreshold terminates (see block 142).
- the controller may initiate a stimulation with prelook (see block 150) during beat to beat, autocapture or autothreshold determination.
- the controller first sets an early detection threshold equal to two times a predetermined amount "N" and enables the early detection threshold a predetermined time immediately before delivering the stimulation pulse (see blocks 152 and 154.
- the early detection threshold may be determined in a manner similar to determining the event threshold as described in co-pending application serial number 09/094,773 filed June 15, 1998 and assigned to the same assignee as the present application, the entire disclosure of which is incorporated herein by reference for any purpose.
- the controller determines whether the amplitude of a portion of the electrogram signal received during the predetermined time immediately before delivering exceeds the early detection threshold (see decision block 156). If the amplitude of a portion of the electrogram signal does not exceed the early detection threshold, then the stimulation pulse is delivered (see loop 158 and block 160). If the amplitude of a portion of the electrogram signal exceeds the early detection threshold, then delivery of the stimulation pulse is delayed by a predetermined amount (see block 162) and the portion of the electrogram signal is analyzed to determine whether an intrinsic event has occurred (see decision block). If no intrinsic event is detected then a backup pace is delivered having an output sufficient to assume capture (see block 166).
Landscapes
- Health & Medical Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Electrotherapy Devices (AREA)
Abstract
This invention is a method for reducing the affects of intrinsic detection latency in a cardiac rhythm management device, wherein said method is initiated immediately prior to delivering a stimulation pulse to the heart tissue. A coincidence of intrinsic cardiac rhythm management initiated stimulus, or the delivery of a stimulation pulse proximate the time of an intrinsic event due to intrinsic detection latency may result in delivery of unnecessary backup stimulus (22), and or imprecise determination of a pacing threshold. When stimulating the heart, the timing sequence for delivering a stimulation pulse typically depends upon the timing of a previous intrinsic (10) or device initiated event. Further, the method of the present invention reduces the affects of intrinsic detection latency thereby facilitating improved detection of capture (14), and determination of capture threshold for minimizing power consumption while assuring therapeutic efficacy.
Description
PSEUDO-FUSION MANAGEMENT DURING
AUTOMATIC CAPTURE VERIFICATION
BACKGROUND OF THE INVENTION
I. Field of the Invention: The present invention relates generally to a method of delivering a stimulation pulse to a patient's heart utilizing a cardiac rhythm management device, and more particularly relates to a method of reducing the affects of intrinsic detection latency during an automatic capture and/or sensing threshold determination. The method of the present invention is initiated immediately prior to delivering a stimulation pulse to the heart tissue, wherein delivery of the stimulation is terminated or delayed if the amplitude of a portion of a sensed electrogram signal exceeds a predetermined threshold. Further, the method of the present invention minimizes the delivery of stimulation pulses proximate in time with an intrinsic event due to intrinsic detection latency (pseudo-fusion).
II. Discussion of the Related Art: Cardiac rhythm management devices have enjoyed widespread use and popularity throughout time as a means for supplanting some or all of the natural pacing functions of an abnormal heart. Among the various heart abnormalities remedied by cardiac rhythm management devices include total or partial heart block, bradycardia, tachycardia, myocardial infarctions, congestive heart failure, congenital heart disorders, and various other arrhythmias and rhythm disturbances within the heart. The fundamental components of a rhythm management device include an electronic pulse generator for generating stimulation pulses to the heart and an electrode arrangement for both delivering the stimulation pulses and sensing intrinsic and/or evoked events of the heart.
Conventional rhythm management devices may be designed to stimulate the ventricle, atrium or both the ventricles and atriums depending upon the heart abnormality. Regardless of the type of rhythm management device employed to restore the heart's natural rhythm, all operate to stimulate heart tissue cells adjacent to an electrode which is employed in the heart and electrically coupled to the rhythm management device. The delivery of the stimulation pulse is often dependent upon a preprogrammed timing sequence. Without limitation, the timing sequence may, for example, depend upon sensing or failure to sense an intrinsic event during a period that is measured from a previous sensed intrinsic event or prior stimulation. If certain
predetermined requirements are not met during the timing sequence, then the rhythm management device may be preprogrammed to generate and deliver a stimulation pulse to the heart. When the stimulation evokes a response in the heart, this response is typically referred to as "capture" and is a function of the positive and negative charges found in each myocardial cell within the heart.
The success of the cardiac rhythm management device in depolarizing or "capturing" the heart hinges on whether the energy of the stimulation pulse as delivered to the myocardium exceeds a threshold value. This threshold value, referred to as the capture threshold, represents the amount of electrical energy required to alter the permeability of the myocardial cells to thereby initiate cell depolarization. If the energy of the stimulation pulse does not exceed the capture threshold, then the permeability of the myocardial cells will not be altered and thus no depolarization will result. If, on the other hand, the energy of the stimulation pulse exceeds the capture threshold, then the permeability of the myocardial cells will be altered such that depolarization will result. Changes in the capture threshold may be detected by monitoring the efficacy of stimulating pulses at various energy levels.
The ability to detect capture is extremely desirable in that delivering stimulation pulses having energy far in excess of the patient's capture threshold is wasteful of the rhythm management devices limited power supply. In order to minimize current drain on the power supply, it is desirable to automatically adjust the rhythm management device such that the amount of stimulation energy delivered to the myocardium is maintained at the lowest level that will reliably capture the heart. To accomplish this, a process known as "capture verification" must be performed wherein the rhythm management device monitors to determine whether an evoked depolarization or intrinsic event occurs in the heart following the delivery of each stimulus pulse. At times, a stimulation pulse may be delivered coincidental to a depolarization by an intrinsic beat (hereinafter referred to as "fusion" or "a fusion beat"). From a surface ECG, the fusion beats manifest themselves by a pacing spike followed by an intrinsic QRS complex. Further, due to intrinsic detection latency, a stimulation pulse may be delivered after intrinsic activation has already begun (hereinafter referred to as pseudo-fusion). From a surface ECG, it is seen that the stimulation pulse falls inside the intrinsic QRS complex. The stimulation pulses may or may not capture the myocardium. During normal delivery of a stimulation pulse, fusion
and/or pseudo-fusion beats may be of little consequence except some energy loss due to unnecessary pacing output. However, during autocapture or autothresholding, the impact of fusion or pseudo-fusion can be rather different.
During autocapture or autothreshold, fusion beats may be detected as capture for amplitude-based detection methods. Thus, even though the stimulation pulse may be below threshold, the evoked response detection remains positive. As a result, the threshold may be identified at a lower amount than the actual threshold. Pseudo-fusion may be detected either as capture or non-capture depending upon timing of the occurrence of pseudo-fusion. If a stimulation pulse is delivered at an earlier portion of the QRS complex, then the stimulation pulse is more likely to be detected as capture and the consequence is the same as a fusion beat. If pseudo-fusion is detected as non-capture, a backup pulse may be issued between the QRS complex and a T wave which is undesirable.
During automatic threshold determination, pseudo-fusion beats may cause false detection of either capture or non-capture. When pseudo-fusion is detected as capture, an error in threshold measurement may arise. In many instances, occurrence of pseudo-fusion is caused by the inherent latency of sensing an intrinsic event. This latency often results from a sensing threshold level that is normally higher than front portions of the QRS complex of the endocardial signals, which prevents a detection by the rhythm management device of the front portions of the QRS complex. Other factors that may contribute to latency in intrinsic detection include sensing channel phase delay. Thus, there is a need for a method that reduces unnecessary autothresholding, error in threshold measurement, and other undesirable affects of fusion and pseudo-fusion during capture verification and autothreshold determination. There is a further need for a method that manages the timing of delivery of backup stimulation that avoids stimulating during undesirable portions of a timing cycle. SUMMARY OF THE INVENTION
The purpose of the present invention is to provide a method of delivering a stimulation pulse to a patient's heart utilizing a cardiac rhythm management device, wherein the method reduces the affects of intrinsic detection latency during an automatic capture and/or sensing threshold determination. Those skilled in the art will appreciate that the method of the present invention may be implemented in cardiac pacers, defibrillators and other rhythm management devices. For purposes of discussion, ease of clarity, and without any limitation intended, the
method of delivering stimulation pulses to a patient's heart will be described with reference to pacing a patient's heart and the timing sequences utilized in pacing the heart. Those skilled in the art will appreciate that the method of the present invention may equally apply to other rhythm management devices including defibrillators having known conventional timing sequences.
The method of the present invention utilizes a cardiac rhythm management device of suitable known construction, wherein the rhythm management device includes sensing means for sensing cardiac electrogram signals, a programmable controller coupled to receive the sensed electrogram signals, and stimulation means controlled by the controller for applying cardiac stimulation pulses to a patient's heart in response to control signals from the controller. Without limitation, the stimulation means and sensing means may comprise circuitry electrically coupled a part of the controller. The programmable controller may be programmed to function utilizing the following sequence for initiating and delivering a stimulation pulse on a beat to beat basis or during an autocapture or autothreshold determination. First, the sensing circuit or sensing means is set to include a first sensing threshold level.
As the rhythm management device receives and analyzes the cardiac electrogram signals, the controller utilizes a stimulation timing sequence that determines when the next stimulation pulse should be delivered. Those skilled in the art will appreciate that the determination of when the stimulation pulse is delivered may depend on several variables and includes a predetermined timing sequence that depends on the last sensed intrinsic event or prior delivered stimulation pulse. Within a first preset time prior to transmitting the stimulation pulse, the controller analyzes the electrogram signals to determine if an amplitude of a portion of the electrogram signals exceeds the first sensing threshold level. Without limitation, other means of known suitable construction may be utilized to determine whether an intrinsic event has been initiated. If the amplitude exceeds the first sensing threshold level, then delivery of the stimulation pulse is delayed by a second preset time. The controller then determines whether an intrinsic event occurs during the second preset time. If no intrinsic event occurs during the second preset time, then a backup stimulation pulse having a predetermined output is delivered to the heart, wherein the output of the backup stimulation pulse is sufficient such that capture of the stimulus may be assumed.
As mentioned above, the stimulation sequence may be adapted by the controller during beat to beat delivery of a stimulation pulse or when delivering a stimulation pulse during autocapture or autothreshold determination. During the stimulation sequence, if the amplitude of a portion of the electrogram signal does not exceed the first sensing threshold level within the first preset time, then the likelihood of fusion or pseudo-fusion is remote and the stimulation pulse is delivered in accordance with the prescribed timing sequence. If an intrinsic event occurs during the second preset time, a preset R-R interval of the timing sequence is extended.
The method of the present invention enhances early intrinsic detection threshold to monitor lower level intracardiac activities. Without any limitation intended, the event threshold or first sensing threshold may be set at 0.5 millivolts. One suitable determination of the sensing threshold is described in greater detail in co-pending application serial number 09/094,773 filed June 15, 1998 and assigned to the same assignee as the present application, the entire disclosure of which is incorporated herein by reference for any purpose.
Those skilled in the art will appreciate that reference to autothreshold refers to a f lly automated method of measuring the stimulation threshold in either the atrium or ventricle. Autothreshold determination is distinguishable from a semi-automatic threshold test during which the operator identifies whether or not a pacing stimulus is followed by a causal depolarization. Also, as will be described in greater detail below, autothreshold determination is distinguishable from automatic capture detection or automatic output optimization. Unlike these features, autothreshold determination does not change the output values of the stimulation pulse. The controller preferably autonomously performs amplitude threshold testing periodically in order to collect a chronological trend that can be interrogated and analyzed during follow-up procedures. The threshold results can be displayed in histogram format and the programmer can suggest a safety margin based on the distribution characteristics of the threshold test results. OBJECTS
It is accordingly a principal object of the present invention to provide a cardiac rhythm management device that reduces potential error in autocapture and autothreshold determination.
Another object of the present invention is to provide a cardiac rhythm management device that manages the timing of the delivery of stimulation pulses to initiate the delivery during predetermined portions of the timing cycle.
Yet another object of the present invention is to provide a cardiac rhythm management device that minimizes the delivery of stimulation pulses proximate in time with an intrinsic event due to intrinsic detection latency (pseudo-fusion).
Still another object of the present invention is to provide a cardiac rhythm management device that reduces the affects of fusion and pseudo-fusion during autocapture and autothreshold determination.
Without limitation, these and other objects as well as these and other advantages of the present invention will become readily apparent to those skilled in the art from a review of the following detailed description of the preferred embodiment especially when considered in conjunction with the claims and accompanying drawings in which like numerals in the several views refer to corresponding parts.
BRIEF DESCRIPTION OF THE DRAWINGS Figure 1 is a partial sectional fragmentary view of a patient's heart having atrial and ventricular leads positioned therein, and a strip chart tracing of an electrogram waveform identifying capture, non-capture and fusion together with the corresponding strip chart tracing of a surface ECG shown for comparison and reference;
Figure 2 is a graph showing pseudo-fusion which is detected as non-capture and resulting in pacing during an intrinsic and a backup pace proximate in time with a t-wave or vulnerable period following an intrinsic event; Figure 3 are graphs showing the timing of a stimulation pulse delivered during various stages of a captured or intrinsic event;
Figure 4 shows a strip chart tracing showing "pseudo-fusions" detected as capture and non-capture and the resulting stimulation sequences, together with a strip chart tracing of a surface ECG for reference; Figure 5 shows a strip chart tracing showing the stimulation sequence including two
"pre-looks", together with a strip chart tracing of a surface ECG for reference;
Figure 6 is a flow chart showing a beat by beat capture verification sequence that includes delivery of a stimulation pulse with a pre-look;
Figure 7 is a flow chart showing an autothreshold sequence that includes delivering a stimulation pulse with a pre-look; and
Figure 8 is a flow chart showing the delivery of a stimulation pulse with a pre-look.
DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT
In conjunction with the several views of the figures, details of a representative embodiment of a cardiac rhythm management device incorporating the features of the present invention will next be presented. Although the present invention may find application in a variety of implantable or external cardiac rhythm management devices, including but not limited to bradycardia pacemakers, antitachycardia pacemakers, and defibrillators, for purposes of explanation, the present invention will be described in connection with an implantable rate adaptive cardiac pacemaker. The rhythm management device may include a programmable controller having pacing and sensing circuitry and may also include read-only memory (ROM) and random access memory (RAM) communicatively coupled to the programmable controller.
The cardiac rhythm management device may likewise include a transceiver cooperatively operable with an input/output module to thereby transmit and receive information to and from an external programmer. Electrodes of known suitable construction are electrically coupled to the cardiac rhythm management device and the controller contained therein, such that a stimulation pulse may be delivered to a desired location of the heart through the electrodes.
Turning now to the Figures, a strip chart and graph are shown in Figures 1 and 2, wherein the affects of fusion and pseudo-fusion in a pacing scheme are shown. The three waveforms 11, 13, and 15 correspond to a signal transmitted from a surface electrocardiogram, an associated pacing marker, and a processed signal transmitted from an intracardiogram respectively. The timing sequence in Figure 1 shows an intrinsic event 10 and then a period of time transpiring without a detection of another intrinsic event. After a predetermined amount of time transpires without detecting an intrinsic event, a pacing stimulus 12 is delivered which evokes a response at 14. The timing sequence shown in Figure 1 continues to deliver pacing stimulus if an intrinsic event is not sensed within a predetermined time. The pacing stimulus 16 is delivered in accordance with the predetermined timing sequence, but results in a fusion beat because the pacing stimulus 16 is delivered at the beginning of an intrinsic event 18. Although fusion and capture may be distinguished from a surface electrocardiogram waveform, fusion and capture beats are not distinguishable from the intracardiogram waveform 15.
As seen in Figure 2, a pacing stimulus 20 may be delivered during a QRS complex, thus requiring a backup pace 22 proximate the T-wave or vulnerable period 24. Delivery of a backup pace 22 proximate the vulnerable period may lead to an undesirable arrhythmia and may be
avoided by reducing fusion and pseudo-fusion during autocapture and autothreshold determination. Figure 3 further illustrates four possible timing sequences when delivery of a pacing stimulus 26. The timing sequence identified as "Capture" shows delivery of a pacing stimulus that evokes a response. The other three timing sequences show delivery of a pacing stimulus proximate with an intrinsic event 28.
Referring now to Figures 4 and 5, strip charts of a portion of an electrogram single are shown which illustrate the affects of fusion and pseudo-fusion on a pacing interval and mode (see Figure 4) and the implementation of the present invention to avoid fusion and pseudo-fusion (see Figure 5). The waveforms 30-34 and associated pacing marker 36 shown in Figure 4 illustrate the affects of a fusion or pseudo-fusion beat on the ability to accurately determine capture or autothreshold. The waveform 30 results from a signal transmitted from a surface electrocardiogram. The waveform 32 results from a signal transmitted from an intracardiogram and processed through a wideband channel of approximately 6-200Hz. The waveform 34 results from a signal transmitted from an intracardiogram and processed through a narrower band channel of approximately 10-100Hz. The intrinsic event identified at 38 is not identified by the pacer and therefore a pace 40 is initiated followed by a backup pace. The pacing stimulus does not evoke a response and the controller process then concludes that the pacing stimulus at 40 did not evoke a response (non-capture). The pacing stimulus at 42 immediately precedes an intrinsic event 44, which results in a fusion beat and also affects an accurate determination of capture. The waveforms 56-60 and associated pacing marker 62 shown in Figure 5 illustrates delivery of a pacing stimulus with a pre-look. The waveform 56 results from a signal transmitted from a surface electrocardiogram. The waveform 58 results from a signal transmitted from an intracardiogram and processed through a wideband channel of approximately 6-200Hz. The waveform 60 results from a signal transmitted from an intracardiogram and processed through a narrower band channel of approximately 10- 100Hz.
Referring now to Figure 6, without any limitation intended the sequence of WI beat by beat capture verification utilizing the method of the present invention is shown in a flowchart diagram. A controller of the rhythm management device initiates a beat by beat capture verification at block 80. The controller then updates the evoked response detection threshold (see block 82) and a determination is made whether an intrinsic event is sensed or whether the amplitude of a selected portion of the electrogram signal exceeds the intrinsic detection
threshold (see decision block 84). If an intrinsic event is sensed, the controller determines if an intrinsic event is sensed in the next cycle (see loop 86). If an intrinsic event is not sensed, then the RR interval of the various pacing intervals is restored to the preset amount (assuming that the RR interval had been extended; see block 88) and a pacing stimulation is delivered with prelook (see block 90). Delivery of a stimulation pulse with prelook will be further discussed below in conjunction with a discussion of Figure 8. After a stimulation pulse is delivered, the controller determines whether the output or pacing stimulus results in an evoked response or capture (see decision block 92). If the stimulation pulse results in capture, the evoked response detection threshold is updated and the previous steps are repeated (see loop 94) and beat by beat pacing continues. If the pacing stimulus does not result in capture at decision block 92, then the controller initiates a backup pace within a predetermined time (see block 96) and the RR interval is extended by a predetermined amount (see block 98). Without limitation, the backup pace is preferably initiated within 100ms and the RR interval is extended by 10% or by 80 ms. The controller then determines whether an intrinsic event occurs within a predetermined time (see decision block 100). If an intrinsic event is sensed at decision block 100, then the extended RR interval is kept and the controller determines if an intrinsic event is sensed in the next cycle (see loop 102 and block 104). If an intrinsic event is not sensed at decision block 100, then a stimulation pulse with prelook is delivered (see block 106) and capture of this pulse is determined (see decision block 108). If the stimulation with prelook results in capture then beat by beat pacing continues (see loop 110). If, however, the stimulation with prelook does not evoke a response, then a backup pace is initiated within a predetermined time (see block 112) and the controller switches to an autothreshold determination.
Figure 7 is a flowchart representation of an autothreshold determination of the present invention. First the evoked response detection threshold is set or updated (see block 116). A stimulation pulse with prelook is delivered having a predetermined output (see block 118) and the controller determines whether the stimulation pulse evokes an intrinsic response (see decision block 120). If the stimulation pulse results in capture, the pacing output is updated (see block 122) and the pacing output is compared with a preset minimum threshold output (see decision block 124). If the pacing output is equal to the preset minimum threshold output, then autothreshold determination is terminated (see block 126). If the updated pacing output is above the minimum preset amount, then, without limitation, the pacing rate is updated for every
third beat (see block 128) by extending the RR interval as described previously and autothreshold determination continues (see loop 130). If the stimulation pulse is not captured at decision block 120, then a backup pace having a predetermined output is delivered (see block 132) and the controller attempts to confirm non-capture (see decision block 134). If the controller does not confirm non-capture, then the pacing output remains the same, the RR interval is extended (see block 136) and autothreshold determination continues (see loop 138). If, however, the output results in non-capture, the threshold is set equal to the previous pace output level (see block 140) and autothreshold terminates (see block 142).
Referring now to Figure 8, the delivery of a stimulation pulse with prelook will now be described. The controller may initiate a stimulation with prelook (see block 150) during beat to beat, autocapture or autothreshold determination. The controller first sets an early detection threshold equal to two times a predetermined amount "N" and enables the early detection threshold a predetermined time immediately before delivering the stimulation pulse (see blocks 152 and 154. Those skilled in the art will appreciate that the early detection threshold may be determined in a manner similar to determining the event threshold as described in co-pending application serial number 09/094,773 filed June 15, 1998 and assigned to the same assignee as the present application, the entire disclosure of which is incorporated herein by reference for any purpose. The controller then determines whether the amplitude of a portion of the electrogram signal received during the predetermined time immediately before delivering exceeds the early detection threshold (see decision block 156). If the amplitude of a portion of the electrogram signal does not exceed the early detection threshold, then the stimulation pulse is delivered (see loop 158 and block 160). If the amplitude of a portion of the electrogram signal exceeds the early detection threshold, then delivery of the stimulation pulse is delayed by a predetermined amount (see block 162) and the portion of the electrogram signal is analyzed to determine whether an intrinsic event has occurred (see decision block). If no intrinsic event is detected then a backup pace is delivered having an output sufficient to assume capture (see block 166).
If an intrinsic event is detected at decision block 164, then the RR interval is extended as described above (see block 168 and continues to be extended until an intrinsic event is not detected (see loop 170), at which time a backup pace is delivered (see block 166). This invention has been described herein in considerable detail in order to comply with the Patent Statutes and to provide those skilled in the art with the information needed to apply
-l ithe novel principles and to construct and use such specialized components as are required. However, it is to be understood that the invention can be carried out by specifically different equipment and devices, and that various modifications, both as to the equipment details and operating procedures, can be accomplished without departing from the scope of the invention itself.
What is claimed is:
Claims
1. A method of reducing the affects of intrinsic detection latency in a cardiac rhythm management device, the cardiac rhythm management device being of the type having means for sensing cardiac electrogram signals, a programmable controller coupled to receive the sensed electrogram signals, and stimulation means controlled by the controller for applying cardiac stimulation pulses to a patient's heart in response to control signals from the controller on a beat-to-beat basis, said method comprising the steps of:
(a) setting a first sensing threshold level;
(b) sensing cardiac electrogram signals; (c) within a first preset time prior to transmitting a stimulation pulse, analyzing the electrogram signals to determine if an amplitude of a portion of the electrogram signals exceeds the first sensing threshold level; (d) if the amplitude exceeds the first sensing threshold level, then delay stimulating for a second preset time; (e) determining whether an intrinsic event occurs during the second preset time; and
(f) if no intrinsic event occurs during the second preset time, delivering a backup stimulus having a predetermined output and assume capture of the backup stimulus.
2. The method in accordance with claim 1, wherein if the amplitude does not exceed the first sensing threshold level within the first preset time, then transmitting the stimulation pulse.
3. The method in accordance with claim 1, wherein said method further includes the step of extending a preset R-R interval of the cardiac rhythm management device by a preset amount if an intrinsic event occurs during the second preset time.
4. The method in accordance with claim 1, wherein said first preset time is dependent upon a timing period for enabling the stimulation pulses.
5. The method in accordance with claim 1, wherein said method is utilized by the cardiac rhythm management device during beat by beat capture verification.
6. The method in accordance with claim 3, wherein said method is utilized by the cardiac rhythm management device during beat by beat capture verification.
7. The method in accordance with claim 4, wherein said method is utilized by the cardiac rhythm management device during beat by beat capture verification.
8. The method in accordance with claim 1, wherein said method is utilized by the cardiac rhythm management device during an autothreshold determination.
9. The method in accordance with claim 3, wherein said method is utilized by the cardiac rhythm management device during an autothreshold determination.
10. The method in accordance with claim 4, wherein said method is utilized by the cardiac rhythm management device during an autothreshold determination.
11. A method of reducing the affects of intrinsic detection latency in a cardiac rhythm management device, the cardiac rhythm management device being of the type having means for sensing cardiac electrogram signals, a programmable controller coupled to receive the sensed electrogram signals, and stimulation means controlled by the controller for applying cardiac stimulation pulses to a patient's heart in response to control signals from the controller on a beat-to-beat basis, said method comprising the steps of: a) setting a first evoked response detection threshold; b) sensing cardiac electrogram signals; c) if no cardiac electrogram signals are detected during a predetermined period having an amplitude exceeding a predefined threshold, then setting an R-R interval of the cardiac rhythm management device to a preset R-R interval; d) transmitting a first stimulation with a prelook; and e) if the first stimulation with prelook results in an evoked response, then repeat steps a) - d).
12. The method in accordance with claim 11, wherein transmitting the first stimulation with prelook includes the following steps: aa) setting a first sensing threshold level; bb) sensing cardiac electrogram signals; cc) within a first preset time, analyzing the electrogram signals to determine if an amplitude of a portion of the electrogram signals exceeds the first sensing threshold level; dd) if the amplitude exceeds the first sensing threshold level, then delay stimulating for a second preset time; ee) determining whether an intrinsic event occurs during the second preset time; and ff) if no intrinsic event occurs during the second preset time, initiate a backup stimulus and assume capture of the stimulation pulses.
13. The method in accordance with claim 11 , wherein when the first stimulation with prelook does not evoke response, then further including the following steps, f) initiate a backup stimulation, extend the R-R interval of the cardiac rhythm management device by a predetermined amount and sense for an intrinsic event during a second predefined period; g) if no intrinsic event is sensed during the second predefined period, then transmit a second stimulation with prelook; and h) determine whether the second stimulation with prelook evokes response; i) if the second stimulation with prelook evokes response, then repeat the method beginning with step b).
14. The method in accordance with claim 13, further including the following steps, wherein if the second stimulation with prelook does not evoke response, then initiate a backup stimulus and initiate an autothreshold.
5. The method in accordance with claim 14, wherein said autothreshold includes stimulation with the prelook.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP99946707A EP1163027A4 (en) | 1999-03-02 | 1999-09-01 | Pseudo-fusion management during automatic capture verification |
AU59057/99A AU5905799A (en) | 1999-03-02 | 1999-09-01 | Pseudo-fusion management during automatic capture verification |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/260,943 US6038474A (en) | 1999-03-02 | 1999-03-02 | Pseudo-fusion management during automatic capture verification |
US09/260,943 | 1999-03-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2000051679A1 true WO2000051679A1 (en) | 2000-09-08 |
Family
ID=22991297
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1999/019983 WO2000051679A1 (en) | 1999-03-02 | 1999-09-01 | Pseudo-fusion management during automatic capture verification |
Country Status (4)
Country | Link |
---|---|
US (2) | US6038474A (en) |
EP (1) | EP1163027A4 (en) |
AU (1) | AU5905799A (en) |
WO (1) | WO2000051679A1 (en) |
Families Citing this family (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6456881B1 (en) | 2000-08-02 | 2002-09-24 | Pacesetter, Inc. | System and method of identifying fusion for dual-chamber automatic capture stimulation device |
US6587723B1 (en) * | 2000-10-17 | 2003-07-01 | Pacesetter, Inc. | Method and system for automatically measuring capture threshold in an implantable cardiac stimulation device |
US6498950B1 (en) * | 2000-10-17 | 2002-12-24 | Pacesetter, Inc. | Implantable cardiac stimulation device having optimized AV/PV delays for improved atrial kick during automatic capture and threshold determinations |
US6643549B1 (en) | 2001-10-30 | 2003-11-04 | Kerry Bradley | Cardiac stimulation device and method for storing diagnostic data in an automatic capture system |
US6950704B1 (en) | 2001-11-01 | 2005-09-27 | Pacesetter, Inc. | Use of ER signal variability for fusion detection and response in ventricular and atrial autocapture algorithms |
US7158831B2 (en) * | 2002-09-13 | 2007-01-02 | Cardiac Pacemakers, Inc. | Method and apparatus for cardiac pacing with variable safety margin |
US7144507B2 (en) * | 2002-12-11 | 2006-12-05 | Paul Baskis | Dry cycle anaerobic digester |
US7191004B2 (en) * | 2002-12-31 | 2007-03-13 | Cardiac Pacemakers, Inc. | Capture verification using an evoked response reference |
US7162301B2 (en) * | 2002-12-31 | 2007-01-09 | Cardiac Pacemakers, Inc. | Method and system for detecting capture with cancellation of pacing artifact |
US7477932B2 (en) * | 2003-05-28 | 2009-01-13 | Cardiac Pacemakers, Inc. | Cardiac waveform template creation, maintenance and use |
US7225020B1 (en) | 2003-09-08 | 2007-05-29 | Pacesetter, Inc. | System and method for providing preventive overdrive pacing and antitachycardia pacing using an implantable cardiac stimulation device |
US7212855B1 (en) | 2003-09-08 | 2007-05-01 | Pacesetter, Inc. | System and method for providing preventive overdrive pacing and antitachycardia pacing using an implantable cardiac stimulation device |
US7363081B1 (en) * | 2003-09-08 | 2008-04-22 | Pacesetter, Inc. | System and method for providing preventive overdrive pacing and antitachycardia pacing using an implantable cardiac stimulation device |
US7319900B2 (en) * | 2003-12-11 | 2008-01-15 | Cardiac Pacemakers, Inc. | Cardiac response classification using multiple classification windows |
US20060247693A1 (en) * | 2005-04-28 | 2006-11-02 | Yanting Dong | Non-captured intrinsic discrimination in cardiac pacing response classification |
US7774064B2 (en) | 2003-12-12 | 2010-08-10 | Cardiac Pacemakers, Inc. | Cardiac response classification using retriggerable classification windows |
US8521284B2 (en) | 2003-12-12 | 2013-08-27 | Cardiac Pacemakers, Inc. | Cardiac response classification using multisite sensing and pacing |
US7181284B2 (en) * | 2004-03-17 | 2007-02-20 | Medtronic, Inc. | Apparatus and methods of energy efficient, atrial-based Bi-ventricular fusion-pacing |
US7706866B2 (en) * | 2004-06-24 | 2010-04-27 | Cardiac Pacemakers, Inc. | Automatic orientation determination for ECG measurements using multiple electrodes |
US7917196B2 (en) | 2005-05-09 | 2011-03-29 | Cardiac Pacemakers, Inc. | Arrhythmia discrimination using electrocardiograms sensed from multiple implanted electrodes |
US7457664B2 (en) * | 2005-05-09 | 2008-11-25 | Cardiac Pacemakers, Inc. | Closed loop cardiac resynchronization therapy using cardiac activation sequence information |
US7805185B2 (en) | 2005-05-09 | 2010-09-28 | Cardiac Pacemakers, In. | Posture monitoring using cardiac activation sequences |
US7890159B2 (en) | 2004-09-30 | 2011-02-15 | Cardiac Pacemakers, Inc. | Cardiac activation sequence monitoring and tracking |
US7509170B2 (en) * | 2005-05-09 | 2009-03-24 | Cardiac Pacemakers, Inc. | Automatic capture verification using electrocardiograms sensed from multiple implanted electrodes |
US7797036B2 (en) | 2004-11-30 | 2010-09-14 | Cardiac Pacemakers, Inc. | Cardiac activation sequence monitoring for ischemia detection |
US7761162B2 (en) * | 2004-12-13 | 2010-07-20 | Cardiac Pacemakers, Inc. | Capture verification with intrinsic response discrimination |
US7734347B2 (en) * | 2004-12-15 | 2010-06-08 | Cardiac Pacemakers, Inc. | Cardiac pacing response classification based on waveform feature variability |
US7908006B2 (en) * | 2004-12-15 | 2011-03-15 | Cardiac Pacemakers, Inc. | Cardiac pacing response classification using an adaptable classification interval |
WO2006065707A2 (en) | 2004-12-15 | 2006-06-22 | Cardiac Pacemakers, Inc. | Cardiac capture verification and retrograde management |
US7930029B2 (en) * | 2004-12-15 | 2011-04-19 | Cardiac Pacemakers, Inc. | Template initialization for evoked response detection |
US8229561B2 (en) * | 2004-12-15 | 2012-07-24 | Cardiac Pacemakers, Inc. | Atrial retrograde management |
US7587240B2 (en) * | 2004-12-15 | 2009-09-08 | Cardiac Pacemakers, Inc. | Atrial capture verification |
US7761159B2 (en) * | 2005-03-17 | 2010-07-20 | Cardiac Pacemakers, Inc. | Cardiac rhythm pacing rate selection for automatic capture threshold testing |
US7392086B2 (en) * | 2005-04-26 | 2008-06-24 | Cardiac Pacemakers, Inc. | Implantable cardiac device and method for reduced phrenic nerve stimulation |
US7392088B2 (en) * | 2005-04-28 | 2008-06-24 | Cardiac Pacemakers, Inc. | Capture detection for multi-chamber pacing |
US7765004B2 (en) * | 2005-04-28 | 2010-07-27 | Cardiac Pacemakers, Inc. | Methods and systems for managing fusion and noise in cardiac pacing response classification |
US7574260B2 (en) | 2005-04-28 | 2009-08-11 | Cardiac Pacemakers, Inc. | Adaptive windowing for cardiac waveform discrimination |
US7499751B2 (en) * | 2005-04-28 | 2009-03-03 | Cardiac Pacemakers, Inc. | Cardiac signal template generation using waveform clustering |
US7457666B2 (en) | 2005-05-25 | 2008-11-25 | Cardiac Pacemakers, Inc. | Retrograde atrial sensing for identifying sub-threshold atrial pacing |
US7529578B2 (en) * | 2005-07-12 | 2009-05-05 | Cardiac Pacemakers, Inc. | Multi channel approach to capture verification |
US7894897B1 (en) | 2006-05-03 | 2011-02-22 | Pacesetter, Inc. | Implantable cardiac stimulation device providing enhanced capture threshold management in the presence of fusion beats and method |
US20080004665A1 (en) * | 2006-06-29 | 2008-01-03 | Mccabe Aaron R | Determination of cardiac pacing parameters based on non-localized sensing |
US8527048B2 (en) | 2006-06-29 | 2013-09-03 | Cardiac Pacemakers, Inc. | Local and non-local sensing for cardiac pacing |
US7580741B2 (en) * | 2006-08-18 | 2009-08-25 | Cardiac Pacemakers, Inc. | Method and device for determination of arrhythmia rate zone thresholds using a probability function |
US8209013B2 (en) * | 2006-09-14 | 2012-06-26 | Cardiac Pacemakers, Inc. | Therapeutic electrical stimulation that avoids undesirable activation |
US8712507B2 (en) * | 2006-09-14 | 2014-04-29 | Cardiac Pacemakers, Inc. | Systems and methods for arranging and labeling cardiac episodes |
US8014851B2 (en) * | 2006-09-26 | 2011-09-06 | Cameron Health, Inc. | Signal analysis in implantable cardiac treatment devices |
US20080086177A1 (en) * | 2006-10-09 | 2008-04-10 | Pacesetter, Inc. | System and Related Methods for Monitoring Cardiac Disease Using Pacing Latency Measurements |
US7801610B2 (en) * | 2006-11-17 | 2010-09-21 | Cardiac Pacemakers, Inc. | Methods and systems for management of atrial retrograde conduction and pacemaker mediated tachyarrhythmia |
US8290590B2 (en) | 2006-11-17 | 2012-10-16 | Cardiac Pacemakers, Inc. | Dynamic morphology based atrial automatic threshold |
US7941208B2 (en) * | 2006-11-29 | 2011-05-10 | Cardiac Pacemakers, Inc. | Therapy delivery for identified tachyarrhythmia episode types |
US20080228093A1 (en) * | 2007-03-13 | 2008-09-18 | Yanting Dong | Systems and methods for enhancing cardiac signal features used in morphology discrimination |
US8265736B2 (en) | 2007-08-07 | 2012-09-11 | Cardiac Pacemakers, Inc. | Method and apparatus to perform electrode combination selection |
US9037239B2 (en) | 2007-08-07 | 2015-05-19 | Cardiac Pacemakers, Inc. | Method and apparatus to perform electrode combination selection |
CN101939051B (en) | 2008-02-14 | 2013-07-10 | 心脏起搏器公司 | Method and apparatus for phrenic stimulation detection |
WO2009137502A1 (en) | 2008-05-07 | 2009-11-12 | Cardiac Pacemakers, Inc. | Method and apparatus to ensure consistent left ventricular pacing |
EP2349467B1 (en) | 2008-10-06 | 2017-08-23 | Cardiac Pacemakers, Inc. | Dynamic cardiac resynchronization therapy by tracking intrinsic conduction |
US8452405B2 (en) * | 2009-05-05 | 2013-05-28 | Cardiac Pacemakers, Inc. | Methods and systems for mitigating the occurrence of arrhythmia during atrial pacing |
US8494619B2 (en) * | 2009-05-27 | 2013-07-23 | Cardiac Pacemakers, Inc. | Systems and methods for the generation and display of fusion statistics |
US8121688B2 (en) * | 2009-06-12 | 2012-02-21 | Pacestter, Inc. | Method and system for automatically switching between modes of an implantable medical device |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5312454A (en) * | 1992-12-14 | 1994-05-17 | Medtronic, Inc. | Apparatus and method of automatically adjusting a sensor signal comparator threshold for an oxygen sensing pacemaker |
US5374282A (en) * | 1991-10-31 | 1994-12-20 | Medtronic, Inc. | Automatic sensitivity adjust for cardiac pacemakers |
US6029086A (en) | 1998-06-15 | 2000-02-22 | Cardiac Pacemakers, Inc. | Automatic threshold sensitivity adjustment for cardiac rhythm management devices |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5097832A (en) * | 1990-03-09 | 1992-03-24 | Siemens-Pacesetter, Inc. | System and method for preventing false pacemaker pvc response |
US5103820A (en) * | 1990-08-14 | 1992-04-14 | Medtronic, Inc. | VDD pacemaker with selectable post-ventricular atrial refractory periods |
US5243979A (en) * | 1991-11-15 | 1993-09-14 | Medtronic, Inc. | Method and apparatus for implementing activity sensing in a pulse generator |
US5271395A (en) * | 1992-04-17 | 1993-12-21 | Medtronic, Inc. | Method and apparatus for rate-responsive cardiac pacing |
US5231986A (en) * | 1992-04-27 | 1993-08-03 | Medtronic, Inc. | Method and system for optimizing activity threshold in activity based rate adaptive pacemakers |
US5312453A (en) * | 1992-05-11 | 1994-05-17 | Medtronic, Inc. | Rate responsive cardiac pacemaker and method for work-modulating pacing rate deceleration |
US5312446A (en) * | 1992-08-26 | 1994-05-17 | Medtronic, Inc. | Compressed storage of data in cardiac pacemakers |
US5336244A (en) * | 1992-10-07 | 1994-08-09 | Medtronic, Inc. | Temperature sensor based capture detection for a pacer |
US5342406A (en) * | 1992-10-07 | 1994-08-30 | Medtronic, Inc. | Oxygen sensor based capture detection for a pacer |
US5441524A (en) * | 1993-08-30 | 1995-08-15 | Medtronic, Inc. | Energy efficient multiple sensor cardiac pacemaker |
US5540729A (en) * | 1994-12-19 | 1996-07-30 | Medtronic, Inc. | Movement powered medical pulse generator having a full-wave rectifier with dynamic bias |
US5674258A (en) * | 1995-03-08 | 1997-10-07 | Medtronic, Inc. | Packaged integrated accelerometer |
SE9603865D0 (en) * | 1996-10-21 | 1996-10-21 | Pacesetter Ab | Heart stimulating device |
US5766230A (en) * | 1996-11-06 | 1998-06-16 | Sulzer Intermedics Inc. | Pacemaker with intra-stimulus capture detection |
US6067472A (en) * | 1997-03-12 | 2000-05-23 | Medtronic, Inc. | Pacemaker system and method with improved evoked response and repolarization signal detection |
US5755738A (en) * | 1997-04-22 | 1998-05-26 | Cardiac Pacemakers, Inc. | Automatic sensing level adjustment for implantable cardiac rhythm management devices |
-
1999
- 1999-03-02 US US09/260,943 patent/US6038474A/en not_active Expired - Lifetime
- 1999-09-01 AU AU59057/99A patent/AU5905799A/en not_active Abandoned
- 1999-09-01 EP EP99946707A patent/EP1163027A4/en not_active Withdrawn
- 1999-09-01 WO PCT/US1999/019983 patent/WO2000051679A1/en active Application Filing
- 1999-12-29 US US09/474,193 patent/US6275731B1/en not_active Expired - Lifetime
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5374282A (en) * | 1991-10-31 | 1994-12-20 | Medtronic, Inc. | Automatic sensitivity adjust for cardiac pacemakers |
US5312454A (en) * | 1992-12-14 | 1994-05-17 | Medtronic, Inc. | Apparatus and method of automatically adjusting a sensor signal comparator threshold for an oxygen sensing pacemaker |
US6029086A (en) | 1998-06-15 | 2000-02-22 | Cardiac Pacemakers, Inc. | Automatic threshold sensitivity adjustment for cardiac rhythm management devices |
Also Published As
Publication number | Publication date |
---|---|
US6038474A (en) | 2000-03-14 |
AU5905799A (en) | 2000-09-21 |
EP1163027A1 (en) | 2001-12-19 |
US6275731B1 (en) | 2001-08-14 |
EP1163027A4 (en) | 2007-10-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6038474A (en) | Pseudo-fusion management during automatic capture verification | |
EP1565232B1 (en) | Determining relative depolarization at multiple cardiac sites | |
US7139610B2 (en) | Capture management in multi-site pacing | |
EP0232528B2 (en) | Rate responsive pacing system | |
US6768924B2 (en) | Method and apparatus for capture verification based on propagated electrical activity | |
EP1051223B1 (en) | System for inducing tachycardia utilizing near-field wave sensing | |
US6934587B1 (en) | System and method for automatic atrial capture detection and atrial pacing threshold determination | |
US7424323B1 (en) | Implantable cardiac stimulation device providing autocapture with PMT avoidance and method | |
US20080097543A1 (en) | Cardiac rhythm management system and method | |
US20040082975A1 (en) | Method and system for detecting capture using a coronary vein electrode | |
USRE42933E1 (en) | Method and apparatus for avoiding unwanted sensing in a cardiac rhythm management device | |
CN111886048A (en) | Monitoring of bundle of his pacing capture during ventricular pacing therapy | |
US7139604B1 (en) | Cardiac stimulation system and method for discriminating sinus from non-sinus events | |
EP1339454B1 (en) | Distinguishing valid and invalid cardiac senses | |
US5899929A (en) | System for inducing tachycardia utilizing near field T-wave sensing | |
US6456882B1 (en) | Implantable cardiac stimulation device having automatic capture/threshold capability using a dynamically adjustable safety margin | |
US6061594A (en) | Algorithm for automatically checking the pacing safety margin in cardiac pacing systems | |
US5941830A (en) | System and method for optimal sensing of cardiac events | |
EP0237767B1 (en) | Rate responsive pacing using the ventricular gradient | |
US6052621A (en) | System and method for inducing tachycardia | |
US9364676B2 (en) | Biventricular cardiac stimulator | |
EP1539297B1 (en) | System for cardiac pacing with variable safety margin | |
US6862471B1 (en) | Method and apparatus for blanking T-waves from combipolar atrial cardiac signals based on expected T-wave locations | |
US9020596B2 (en) | Management of fusion beat detection during capture threshold determination | |
US7299094B1 (en) | System and method for implementing autocapture within biventricular implantable cardiac stimulation systems |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1999946707 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1999946707 Country of ref document: EP |